Intra-Cellular Therapies saw the highest growth of 0.99% in patent filings and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Intra-Cellular Therapies‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Intra-Cellular Therapies has been focused on protecting inventions in United States(US) with eight publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 43% grants. The United States(US), Hungary(HU), Israel(IL), and Australia(AU) patent Office are among the top ten patent offices where Intra-Cellular Therapies is filings its patents. Among the top granted patent authorities, Intra-Cellular Therapies has 43% of its grants in United States(US) and 29% in Israel(IL).
Gilead Sciences and Roche could be the strongest competitors for Intra-Cellular Therapies
In terms of grant share, Intra-Cellular Therapies stands first among its competitors followed by Gilead Sciences and Roche.
Patents related to addiction and rare diseases lead Intra-Cellular Therapies's portfolio
Intra-Cellular Therapies has the highest number of patents in addiction followed by, rare diseases and climate change. For addiction, nearly 44% of patents were filed and 80% of patents were granted in Q2 2024.
Hashimoto thyroiditis related patents lead Intra-Cellular Therapies portfolio followed by depression, and schizophrenia
Intra-Cellular Therapies has highest number of patents in hashimoto thyroiditis followed by depression, schizophrenia, psychosis, and dementia. For hashimoto thyroiditis, nearly 5% of patents were filed and 7% of patents were granted in Q2 2024.
For comprehensive analysis of Intra-Cellular Therapies's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
